Post a clear title like ‘Need help preparing PTSD claim’ or “VA med center won’t schedule my surgery”instead of ‘I have a question.
Knowledgeable people who don’t have time to read all posts may skip yours if your need isn’t clear in the title.
I don’t read all posts every login and will gravitate towards those I have more info on.
Use paragraphs instead of one massive, rambling introduction or story.
Again – You want to make it easy for others to help. If your question is buried in a monster paragraph, there are fewer who will investigate to dig it out.
Leading too:
Post straightforward questions and then post background information.
Examples:
Question A. I was previously denied for apnea – Should I refile a claim?
Adding Background information in your post will help members understand what information you are looking for so they can assist you in finding it.
Rephrase the question: I was diagnosed with apnea in service and received a CPAP machine, but the claim was denied in 2008. Should I refile?
Question B. I may have PTSD- how can I be sure?
See how the details below give us a better understanding of what you’re claiming.
Rephrase the question: I was involved in a traumatic incident on base in 1974 and have had nightmares ever since, but I did not go to mental health while enlisted. How can I get help?
This gives members a starting point to ask clarifying questions like “Can you post the Reasons for Denial of your claim?”
Note:
Your first posts on the board may be delayed before they appear as they are reviewed. This process does not take long.
Your first posts on the board may be delayed before they appear as they are reviewed. The review requirement will usually be removed by the 6th post. However, we reserve the right to keep anyone on moderator preview.
This process allows us to remove spam and other junk posts before hitting the board. We want to keep the focus on VA Claims, and this helps us do that.
Most Common VA Disabilities Claimed for Compensation:
You’ve just been rated 100% disabled by the Veterans Affairs. After the excitement of finally having the rating you deserve wears off, you start asking questions. One of the first questions that you might ask is this: It’s a legitimate question – rare is the Veteran that finds themselves sitting on the couch eating bon-bons …Continue reading
Parovirus B19 (B19 virus) was the first human parvovirus to be discovered, by chance in 1975 by the Australian virologist Yvonne Cossart. It gained is name because it was discovered in well B19 of a large series of petri dishes apparently numbered in this way.
Parovirus B19 is best known for causing a childhood exanthem called "fifth disease" (erythema infectiosum).
Virology
The B19 virus belongs to the Parvoviridae family of small DNA viruses. It is classified as Erythrovirus due to its capability to invade red blood cell precursors in the bone marrow.
Transmission
The virus is spread by infected respiratory droplets.
Epidemiology
A significant increase in the number of cases is seen every three to four years; the last epidemic year was 1998. Parvovirus B19 only causes an infection in humans; cat and dog parvoviruses do not infect humans. In contrast with small animals, there is no vaccine available for human parvovirus B19.
Role in disease
Fifth disease
After being infected, patients usually develop the illness after an incubation period of four to fourteen days. The disease commences with fever and malaise while the virus is most abundant in the bloodstream, and patients are usually no longer infectious once the characteristic rash of this disease has appeared.
Any age may be affected, although it is most common in children aged six to ten years. By the time adulthood is reached about half the population will have become immune following infection at some time in their past. Outbreaks can arise especially in nurseries and schools.
Arthritis
In adults (and perhaps some children), parvovirus B19 can lead to a seronegative arthritis which is easily controlled with analgesics. Possibly up to 15% of all new cases of arthritis are due to parvovirus, and a history of recent contact with a patient and positive serology generally confirms the diagnosis. The arthritis does not progress to other forms of arthritis.
Aplastic crisis
Although most patients have an arrest of erythropoiesis (production of red blood cells) during parvovirus infection, it causes problems in patients with sickle cell anemia, who are heavily dependant on erythropoeisis due to the reduced lifespan of the red cells. This is termed "aplastic crisis". It is treated with blood transfusion. Sickle-cell patients will probably be the first candidates to be candidates for a parvovirus B19 vaccine when this is developed.
Hydrops fetalis
Parvovirus infection in pregnant women is associated with hydrops fetalis due to severe fetal anemia, sometimes leading to spontaneous abortion.
Reference
Young NS, Brown KE. Parvovirus B19. N Engl J Med 2004;350:586-97.
Question
Guest allanopie
Microbiology
Email this page</FONT>Parvovirus B19 Author: Wikipedia, Posted on Tuesday, September 14 @ 15:03:19 IST by RxPG
Scientific classification
dsDNA viruses
Family: Parvoviridae
Genus: Erythrovirus
Species: B19 virus
Parovirus B19 (B19 virus) was the first human parvovirus to be discovered, by chance in 1975 by the Australian virologist Yvonne Cossart. It gained is name because it was discovered in well B19 of a large series of petri dishes apparently numbered in this way.
Parovirus B19 is best known for causing a childhood exanthem called "fifth disease" (erythema infectiosum).
Virology
The B19 virus belongs to the Parvoviridae family of small DNA viruses. It is classified as Erythrovirus due to its capability to invade red blood cell precursors in the bone marrow.
Transmission
The virus is spread by infected respiratory droplets.
Epidemiology
A significant increase in the number of cases is seen every three to four years; the last epidemic year was 1998. Parvovirus B19 only causes an infection in humans; cat and dog parvoviruses do not infect humans. In contrast with small animals, there is no vaccine available for human parvovirus B19.
Role in disease
Fifth disease
After being infected, patients usually develop the illness after an incubation period of four to fourteen days. The disease commences with fever and malaise while the virus is most abundant in the bloodstream, and patients are usually no longer infectious once the characteristic rash of this disease has appeared.
Any age may be affected, although it is most common in children aged six to ten years. By the time adulthood is reached about half the population will have become immune following infection at some time in their past. Outbreaks can arise especially in nurseries and schools.
Arthritis
In adults (and perhaps some children), parvovirus B19 can lead to a seronegative arthritis which is easily controlled with analgesics. Possibly up to 15% of all new cases of arthritis are due to parvovirus, and a history of recent contact with a patient and positive serology generally confirms the diagnosis. The arthritis does not progress to other forms of arthritis.
Aplastic crisis
Although most patients have an arrest of erythropoiesis (production of red blood cells) during parvovirus infection, it causes problems in patients with sickle cell anemia, who are heavily dependant on erythropoeisis due to the reduced lifespan of the red cells. This is termed "aplastic crisis". It is treated with blood transfusion. Sickle-cell patients will probably be the first candidates to be candidates for a parvovirus B19 vaccine when this is developed.
Hydrops fetalis
Parvovirus infection in pregnant women is associated with hydrops fetalis due to severe fetal anemia, sometimes leading to spontaneous abortion.
Reference
Young NS, Brown KE. Parvovirus B19. N Engl J Med 2004;350:586-97.
SOURCE:
http://www.rxpgonline.com/article996.html
Link to comment
Share on other sites
Popular Days
Jun 25
1
Popular Days
Jun 25 2006
1 post
0 answers to this question
Recommended Posts